Ranbaxy reports a Net Loss of Rs 616 crore for December Quarter

1. Ranbaxy reports a Net Loss of Rs 616 crore for December Quarter
Ranbaxy Laboratories Ltd
26-Feb-2013 | Quarterly Result as on 31-Dec-2012
For the period the Ranbaxy Laboratories Ltd reported Net Sales of Rs 14415.23 million and Net Loss of Rs 6160.96 million. While Net Sales
declined by 62.92%, Net Profit grown by 77.27% and thereby NPM improved to -42.74% as compared to -69.71% during same period
previous FY Equity Capital for the period under consideration has increased by 0.22% and stands at Rs 2114.57 million. EPS as on 31-Dec-
.
2012 stands at Rs -14.59 viz-a-viz Rs -64.28 as on 31-Dec-2011.
The stock of the Ranbaxy Laboratories Ltd at BSE opened at 439.05 touched a high 439.65 and low 412.25 before closing at 417.30 losing
3.66% over previous close. The trading volume for the stock at BSE stood at 254350 shares and at NSE stood at 1283858 shares.
BSE NSE
The BSE Sensex closed today at 19015.14 (1.64% loss) and Nifty closed at 5761.35 (1.60% loss).
Company Announcements
26-Feb-2013 03:17 PM Fixes Book Closure for AGM
26-Feb-2013 02:59 PM Announces Q4 & FY12 results, Auditors Report & Results Press Release for the per...
View Detailed Result
Follow us on This content is generated at www.finalaya.com and is governed by the Terms of Use.